1-20 of 48
cd19 antigens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fatal late-onset CAR T-cell–mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphoma

Clinical Trials & Observations
Susanne Jung, Jochen Greiner, Stephanie von Harsdorf, Pavle Popovic, Roland Moll, Jens Schittenhelm, Kosmas Kandilaris, Volker Daniel, Alexander Kunz, Michael Schmitt, Peter Dreger
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3789–3793.
https://doi.org/10.1182/bloodadvances.2021004889
Published: 2021
Includes: Supplemental data
Journal Articles

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

Paraskevi Diamanti, Charlotte V. Cox, Benjamin C. Ede, Robert A. Uger, John P. Moppett, Allison Blair
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3694–3708.
https://doi.org/10.1182/bloodadvances.2020003534
Published: 2021
Includes: Supplemental data
Journal Articles

Development and characterization of prototypes for in vitro and in vivo mouse models of ibrutinib-resistant CLL

Burcu Aslan, Gorkem Kismali, Lisa S. Chen, LaKesla R. Iles, Mikhila Mahendra, Michael Peoples, Mihai Gagea, Natalie W. Fowlkes, Xiaofeng Zheng, Jing Wang, Christopher P. Vellano, Joseph R. Marszalek, Maria Teresa Sabrina Bertilaccio, Varsha Gandhi
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3134–3146.
https://doi.org/10.1182/bloodadvances.2020003821
Published: 2021
Includes: Supplemental data
Journal Articles

Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma

Clinical Trials & Observations
Donald L. Patrick, Annette Powers, Monika Parisi Jun, Yeonhee Kim, Jacob Garcia, Christine Dehner, David G. Maloney
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2245–2255.
https://doi.org/10.1182/bloodadvances.2020003503
Published: 2021
Includes: Supplemental data
Journal Articles

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency

Clinical Trials & Observations
Sandheeah Ramdeny, Asima Chaudhary, Austen Worth, Sara Ghorashian, Mary Slatter, Su Han Lum, Ajay Vora
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2153–2155.
https://doi.org/10.1182/bloodadvances.2021004284
Published: 2021
Journal Articles

Absolute lymphocyte count proliferation kinetics after CAR T-cell infusion impact response and relapse

Clinical Trials & Observations
Sophia Faude, Jane Wei, Kavitha Muralidharan, Xiaoming Xu, Gerald Wertheim, Michele Paessler, Vijay G. Bhoj, Stephan A. Grupp, Shannon L. Maude, Susan R. Rheingold, Vinodh Pillai
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2128–2136.
https://doi.org/10.1182/bloodadvances.2020004038
Published: 2021
Includes: Supplemental data
Journal Articles

Cytokine release syndrome and neurological event costs in lisocabtagene maraleucel–treated patients in the TRANSCEND NHL 001 trial

Jeremy S. Abramson, Tanya Siddiqi, Jacob Garcia, Christine Dehner, Yeonhee Kim, Andy Nguyen, Sophie Snyder, November McGarvey, Matthew Gitlin, Corey Pelletier, Monika P. Jun
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1695–1705.
https://doi.org/10.1182/bloodadvances.2020003531
Published: 2021
Journal Articles

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

Clinical Trials & Observations
Luisa Strocchio, Daria Pagliara, Mattia Algeri, Giuseppina Li Pira, Francesca Rossi, Valentina Bertaina, Giovanna Leone, Rita Maria Pinto, Marco Andreani, Emanuele Agolini, Katia Girardi, Stefania Gaspari, Lavinia Grapulin, Francesca del Bufalo, Antonio Novelli, Pietro Merli, Franco Locatelli
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1333–1339.
https://doi.org/10.1182/bloodadvances.2020003707
Published: 2021
Journal Articles

The S enantiomer of 2-hydroxyglutarate increases central memory CD8 populations and improves CAR-T therapy outcome

Iosifina P. Foskolou, Laura Barbieri, Aude Vernet, David Bargiela, Pedro P. Cunha, Pedro Velica, Eunyeong Suh, Sandra Pietsch, Rugile Matuleviciute, Helene Rundqvist, Dominick McIntyre, Ken G. C. Smith, Randall S. Johnson
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4483–4493.
https://doi.org/10.1182/bloodadvances.2020002309
Published: 2020
Includes: Supplemental data
Journal Articles

Primary human herpesvirus 8–negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis

Daisuke Kaji, Yasunori Ota, Yasuharu Sato, Koji Nagafuji, Yasunori Ueda, Masataka Okamoto, Yasushi Terasaki, Naoko Tsuyama, Kosei Matsue, Tomohiro Kinoshita, Go Yamamoto, Shuichi Taniguchi, Shigeru Chiba, Koichi Ohshima, Koji Izutsu
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4442–4450.
https://doi.org/10.1182/bloodadvances.2020002293
Published: 2020
Includes: Supplemental data
Journal Articles

Stable HLA antibodies following sustained CD19 + cell depletion implicate a long-lived plasma cell source

Clinical Trials & Observations
Zheng Zhang, Stephen J. Schuster, Simon F. Lacey, Michael C. Milone, Dimitri Monos, Vijay G. Bhoj
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4292–4295.
https://doi.org/10.1182/bloodadvances.2020002435
Published: 2020
Journal Articles

Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma

Clinical Trials & Observations
Hamza Hashmi, Abu-Sayeef Mirza, Alicia Darwin, Constantine Logothetis, Franco Garcia, Anuhya Kommalapati, Rahul S. Mhaskar, Christina Bachmeier, Julio C. Chavez, Bijal Shah, Javier Pinilla-Ibarz, Farhad Khimani, Aleksandr Lazaryan, Hien Liu, Marco L. Davila, Frederick L. Locke, Taiga Nishihori, Michael D. Jain
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4086–4090.
https://doi.org/10.1182/bloodadvances.2020002060
Published: 2020
Includes: Supplemental data
Journal Articles

Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies

Clinical Trials & Observations
Tania Jain, Andrea Knezevic, Martina Pennisi, Yunxin Chen, Josel D. Ruiz, Terence J. Purdon, Sean M. Devlin, Melody Smith, Gunjan L. Shah, Elizabeth Halton, Claudia Diamonte, Michael Scordo, Craig S. Sauter, Elena Mead, Bianca D. Santomasso, M. Lia Palomba, Connie W. Batlevi, Molly A. Maloy, Sergio Giralt, Eric Smith, Renier Brentjens, Jae H. Park, Miguel-Angel Perales, Sham Mailankody
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3776–3787.
https://doi.org/10.1182/bloodadvances.2020002509
Published: 2020
Includes: Supplemental data
Journal Articles

High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma

Clinical Trials & Observations
Erin A. Dean, Rahul S. Mhaskar, Hong Lu, Mina S. Mousa, Gabriel S. Krivenko, Aleksandr Lazaryan, Christina A. Bachmeier, Julio C. Chavez, Taiga Nishihori, Marco L. Davila, Farhad Khimani, Hien D. Liu, Javier Pinilla-Ibarz, Bijal D. Shah, Michael D. Jain, Yoganand Balagurunathan, Frederick L. Locke
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3268–3276.
https://doi.org/10.1182/bloodadvances.2020001900
Published: 2020
Includes: Supplemental data
Journal Articles

Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia

Clinical Trials & Observations
Ryan D. Cassaday, Kelsey-Leigh A. Garcia, Jonathan R. Fromm, Mary-Elizabeth M. Percival, Cameron J. Turtle, Paul T. Nghiem, Phillip A. Stevenson, Elihu H. Estey
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3239–3245.
https://doi.org/10.1182/bloodadvances.2020002403
Published: 2020
Includes: Supplemental data
Journal Articles

DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality

Clinical Trials & Observations
Kitsada Wudhikarn, Martina Pennisi, Marta Garcia-Recio, Jessica R. Flynn, Aishat Afuye, Mari Lynne Silverberg, Molly A. Maloy, Sean M. Devlin, Connie Lee Batlevi, Gunjan L. Shah, Michael Scordo, Maria Lia Palomba, Parastoo B. Dahi, Craig S. Sauter, Bianca D. Santomasso, Elena Mead, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3024–3033.
https://doi.org/10.1182/bloodadvances.2020001972
Published: 2020
Includes: Supplemental data
Journal Articles

Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

Clinical Trials & Observations
Xian Zhang, Xin-an Lu, Junfang Yang, Gailing Zhang, Jingjing Li, Lisong Song, Yunchao Su, Yanze Shi, Min Zhang, Jiujiang He, Dan Song, Fanyong Lv, Wenqian Li, Yan Wu, Hui Wang, Hongxing Liu, Xiaosu Zhou, Ting He, Peihua Lu
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2325–2338.
https://doi.org/10.1182/bloodadvances.2020001466
Published: 2020
Includes: Supplemental data
Journal Articles

Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8 + T-cell responses

Alak Manna, Timothy Kellett, Sonikpreet Aulakh, Laura J. Lewis-Tuffin, Navnita Dutta, Keith Knutson, Eduardo Chini, Javier Pinilla-Ibarz, Nicole Lamanna, Rami Manochakian, Fabio Malavasi, Taimur Sher, Asher A. Chanan-Khan, Sikander Ailawadhi, Aneel Paulus
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2143–2157.
https://doi.org/10.1182/bloodadvances.2019001091
Published: 2020
Includes: Supplemental data
Journal Articles

Bai X, Huang L, Niu L, et al. Mst1 positively regulates B-cell receptor signaling via CD19 transcriptional levels. Blood Adv. 2016;1(3):219-230.

Journal: Blood Advances
Blood Adv (2020) 4 (9): 1844.
https://doi.org/10.1182/bloodadvances.2020002095
Published: 2020
Journal Articles

Chimeric antigen receptor–T cells with cytokine neutralizing capacity

Adrian H. J. Tan, Natasha Vinanica, Dario Campana
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1419–1431.
https://doi.org/10.1182/bloodadvances.2019001287
Published: 2020
Includes: Supplemental data